SCHEMBL24258056

SCHEMBL24258056

N[C@@H](Cc1ccccc1)c1nc(-c2ccc(=O)[nH]c2)no1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.41
PTPN1 P18031 1/20 0.40
ROCK2 O75116 2/20 0.39
CPT2 P23786 1/20 0.39
CPT1A P50416 1/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TPH1 P17752 2/20 0.37
S1PR1 P21453 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
FFAR1 O14842 1/20 0.36
GPR142 Q7Z601 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15875270 0.82 L3MBTL1 (0.50) HCAR2PTPN1S1PR1ALDH1A1HTT
Hydrochloric Acid SCHEMBL27510587 0.81 L3MBTL1 (0.49) HCAR2PTPN1MEN1KMT2AS1PR1
SCHEMBL24258079 0.77 S1PR1 (0.63) PTPN1CPT2CPT1AS1PR1ALDH1A1
SCHEMBL24258052 0.77 S1PR1 (0.43) CPT2CPT1AS1PR1ALDH1A1PPARD
SCHEMBL20968287 0.77 PPARD (0.53) HCAR2PTPN1TPH1PPARDPPARA
SCHEMBL24258084 0.76 S1PR1 (0.58) MEN1KMT2AS1PR1ALDH1A1HTT
Trifluoroacetic Acid SCHEMBL7092163 0.76 PTPN1 (0.49) HCAR2PTPN1TPH1PPARDPPARA
Trifluoroacetic Acid SCHEMBL6632834 0.76 PTPN1 (0.49) HCAR2PTPN1TPH1PPARDPPARA
SCHEMBL22637690 0.73 PTPN1 (0.49) PTPN1MEN1KMT2ATPH1TDP1
SCHEMBL20657658 0.72 S1PR1 (0.54) S1PR1ALDH1A1HTTPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265082-A1 SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. 2023-08-24 US disclosed
US-20230265082-A1 SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. 2023-08-24 US disclosed
WO-2022035805-A1 SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265082-A1 SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 USP28, USP1, USP18 HCAR2 4604/4885PTPN1 610/4885ROCK2 3377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.